About
Gene therapy for various cancers
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapySan Diego & Southern California
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
250
By Phase
PHASE2: 4
By Status
UNKNOWN: 3AVAILABLE: 2RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT04887311Lead Sponsor
MBM-01 (Tempol) for the Treatment of Ataxia Telangiectasia
PHASE2Unknown
20 participants
Started: Jul 31, 2021 · Completed: Dec 31, 2022
NCT04874506Lead Sponsor
MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)
PHASE2Unknown
55 participants
Started: Jun 1, 2021 · Completed: Aug 31, 2023
NCT04876755Lead Sponsor
MBM-02 (Tempol) for the Treatment of Biochemical Recurrent Prostate Cancer
PHASE2Unknown
55 participants
Started: May 30, 2021 · Completed: Feb 28, 2023
NCT03480971Lead Sponsor
Treatment of Radiation and Cisplatin Induced Toxicities with Tempol
PHASE2Recruiting
120 participants
Started: May 13, 2019 · Completed: Dec 31, 2025
NCT04337099Lead Sponsor
A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate Cancer
N/AAVAILABLE
Locations (1)
Headquarters
Irvine, CA, United States
Map
Loading map...